drugset / Trial / NCT01716611
Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
Phase 4
Unknown
105 enrolled
Konkuk University Medical Center
Chung-Ang University Hospital · collabChungnam National University · collabHallym University Medical Center · collabHanyang University · collabIncheon St.Mary's Hospital · collabInha University Hospital · collabInje University · collabKorea University Anam Hospital · collabKyungpook National University Hospital · collabSamsung Medical Center · collabSeoul St. Mary's Hospital · collabSeverance Hospital · collabSoonchunhyang University Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to investigate the efficacy and safety for the management of hyponatremia and ascites in patients with liver cirrhosis.
Timeline
- Start
- 2012-11
- Primary completion
- 2014-01
- Completion
- 2014-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tolvaptan | Unknown | 15 mg | — |
| Comparator | Tolvaptan | Unknown | 30 mg | — |
| Comparator | Tolvaptan | Unknown | 60 mg | — |
Indications
No indication recorded.